Global Breast Biopsy Devices Market Insights Forecasts to 2033

• The Global Breast Biopsy Devices Market Size was Valued at USD 1.7 Billion in 2023
• The Market Size is Growing at a CAGR of 5.49% from 2023 to 2033
• The Worldwide Breast Biopsy Devices Market Size is Expected to Reach USD 2.9 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

 

The Global Breast Biopsy Devices Market Size is Anticipated to Exceed USD 2.9 Billion by 2033, Growing at a CAGR of 5.49% from 2023 to 2033.

 

Market Overview

The term biopsy devices refers to tools used to remove a sample or tissue of cells from the body for laboratory analysis to determine whether an illness is present. Surgeons, interventional cardiologists, and radiologists employ these devices. Depending on the type of organ being investigated, these biopsy tools are used differently. Women globally have a high mortality rate from breast cancer. Worldwide, breast cancer is a serious concern. Certainly, there is a correlation between a higher risk of triple-negative breast cancer and increasing parity, premenopausal status, and shorter nursing duration. Age has a clear correlation with the risk of breast cancer. Breast surgery retractors are projected to become increasingly in demand due to the growing number of elderly females, the growing awareness of breast cancer, and the significance of early detection. Breast biopsy is done by various procedures, such as fine-needle aspiration biopsy, core needle biopsy, stereotactic biopsy, ultrasound-guided core needle biopsy, MRI-guided core needle biopsy, and surgical biopsy. There are some risks related to breast biopsy, including swelling and bruising of the breast, bleeding or infection at the biopsy site, and changes in breast appearance. The increasing cases of breast cancer will propel the demand for breast biopsy devices presently. The overall burden of breast cancer is growing, attributed to the rising population along with the changing lifestyle and excessive consumption of drinks and cigarettes. In developed and undeveloped countries, breast cancer is a major public health problem. Market players for breast biopsy devices are also focusing on working with ambulatory surgery centers and hospitals for direct sales, equipment maintenance, and staff training to increase awareness of the latest innovations.

 

Report Coverage

This research report categorizes the market for the global breast biopsy devices market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global breast biopsy devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global breast biopsy devices market.

 

Driving Factors

The increasing cases of breast cancer around the world act as one of the key factors propelling the growth of the market. Additionally, breast cancer is particularly common in women over the age of 40, and increasing awareness related to breast cancer protection programs will drive market growth. The rise in the tendency towards minimally invasive surgeries among patients is attributed to the fast recovery and less pain, which drives the growth of the market. Funds and grants for biomarker research in the form of heavy expenditure dominate the growth of the breast biopsy device market.

 

Restraining Factors

The grade and size of the biopsy samples can differ, making it difficult to obtain sufficient tissue for a precise diagnosis. Patients may experience anxiety and fear related to the biopsy method due to problems with complications, pain, or receiving a cancer diagnosis. This can hold up the diagnosis and treatment. Additionally, the demand for breast biopsy equipment is being restricted by the high cost of the devices. The expensive equipment, the high cost associated with high services, and the equipment that is unreachable to most patients in most nations are major market restraints. Furthermore, this procedure requires skilled staff and trainees. In many hospitals and healthcare centers, there is a lack of trained professionals to use these devices during surgeries and diagnoses. Therefore, the lack of skilled staff and other factors are predicted to hinder market growth.

 

Market Segmentation

The global breast biopsy devices market share is classified into product, technique, and end-user.

 

• The biopsy needles segment is anticipated to hold the largest share of the global breast biopsy devices market during the forecast period.    

On the basis of the product, the global breast biopsy devices market is divided into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others. Among these, the biopsy needles segment is anticipated to hold the largest share of the global breast biopsy device market during the forecast period. The biopsy needles are low-cost and sophisticated enough for surgeons and radiologists to use them during the surgeries. To detect the origin of abnormalities, a thin, hollowed needle, and syringe are used to collect samples, like cells, fluids, or tissues from a suspected mass or another abnormal part of the body. These samples are then examined under a microscope or evaluated in a lab. Breast biopsy devices are driven by numerous factors, including the ability to benign ermine the nature of a lump or mass using a needle biopsy, such as a benign tumor, cyst, infection, or cancer.

 

• The liquid biopsy segment is anticipated to hold the largest share of the global breast biopsy devices market during the forecast period.    

On the basis of the technique, the global breast biopsy devices market is divided into image guided biopsy and liquid biopsy. Among these, the liquid biopsy segment is anticipated to hold the largest share of the global breast biopsy devices market during the forecast period. A liquid biopsy is a cutting-edge method that is expanding the scope of cancer diagnosis. The majority of developed countries are increasingly using droplet digital PCR technology and modern NGS-based assays for liquid biopsies, which could account for the notable expansion of the market. Companies in the industry are investing more in R&D to launch new products. Therefore, further market expansion will be driven by ongoing clinical trials and a potential product pipeline.

 

• The hospitals segment is anticipated to hold the largest share of the global breast biopsy devices market during the forecast period.

 On the basis of end-user, the global breast biopsy devices market is divided into hospitals, ambulatory surgical centers, diagnostic centers, and other. Among these, the hospitals segment is anticipated to hold the largest share of the global breast biopsy devices market during the forecast period. Hospitals handle a lot of patients for breast cancer diagnosis and treatment. Companies are also concentrating on novel approaches to train radiologists and surgeons in hospitals to reach more patients, and these are starting to take off. relying on advanced facilities and trained professionals to merge complex biopsy processes easily. Their control over cutting-edge imaging technologies promotes worldwide adoption. Furthermore, patients who believe in hospital-based diagnostic services have a liking for the breast biopsy process in these settings. 

 

Regional Segment Analysis of the Global Breast Biopsy Devices Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the global breast biopsy devices market over the predicted timeframe.

 

Get more details on this report -

Request Free Sample PDF

 

North America is anticipated to hold the largest share of the global breast biopsy device market over the predicted timeframe. The main sources of income for market growth are the U.S. and Canada, the two largest financial states in this region. The advanced healthcare facilities, global access to inventive diagnostic technologies, and dynamic breast cancer awareness camp are the reasons to take the U.S. into the top position in the industry. Moreover, the growing number of breast cancer patients, increasing awareness of breast cancer early identification, improving government funding for breast cancer research, and rising use of devices in cancer research centers in the U.S. are the main factors driving the growth of the breast biopsy device market over the predicted timeframe.

 

Asia-Pacific is anticipated to grow at the fastest rate in the global breast biopsy devices market over the predicted timeframe. The fastest developing countries in the region have invested in the building of healthcare facilities, that propelling the growth of the market. In addition, as the diagnostic market in developing countries becomes more conscious of breast biopsy methods, companies are capable to invest in breast biopsy equipment in this developing market. Fast advancement in health technology in countries, such as India, China, and South Korea have induced hospitals and other breast care facilities to make high cost in innovative technologies. These factors drive the growth of the breast biopsy devices market over the predicted timeframe.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global breast biopsy devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Becton Dickinson and Company
• Cook Medical Inc.
• F. Hoffmann-La Roche Ltd.,
• Hologic, Inc.
• Medax Srl Unipersonale
• Scion Medical Technologies, LLC
• ARGON MEDICAL
• C.R. Bard, Inc.
• Devicor Medical Products, Inc.
• GE Healthcare
• Leica Biosystems
• Siemens Healthier
• Medtronic plc
• Cardinal Health
• INRAD Inc
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

• In May 2023, Argon Medical Devices, a superior device solution for various medical areas, introduces the Advantage Semi-Automatic Biopsy Instrument in the U.S., growing its soft tissue biopsy product line. This planned introduction focused on altering the company’s contribution and increasing revenue.

 

• In August 2022, Mammotome (Danaher Corporation) inaugurated the Mammotome Revolve EX, the first vacuum-assisted biopsy system developed for the systematic excision of benign breast lesions, promoting double the speed as compared to the traditional system. This product expands the company’s product portfolio, providing a significant competitive edge.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global breast biopsy devices market based on the below-mentioned segments: 

 

Global Breast Biopsy Devices Market, By Product

• Biopsy Needles
• Guidance Systems
• Biopsy Tables
• Localization Wires
• Assay Kits
• Liquid Biopsy Instruments
• Others

 

Global Breast Biopsy Devices Market, By Technique

• Image Guided Biopsy
• Liquid Biopsy

 

Global Breast Biopsy Devices Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Other

 

Global Breast Biopsy Devices Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa